Amgen, Celgene, Biogen fall on analyst ratings
August 16, 2010 at 10:44 AM EDT
Analysts at Deutsche Bank initiate coverage of Amgen with a hold rating, citing valuation and weakened sales.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.